Praxis Precision Medicines Inc (PRAX)

NASDAQ
Currency in USD
38.28
+0.99(+2.65%)
Closed
After Hours
38.61+0.33(+0.86%)
PRAX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
37.2638.60
52 wk Range
30.0191.83
Key Statistics
Edit
Prev. Close
37.29
Open
37.75
Day's Range
37.26-38.6
52 wk Range
30.01-91.83
Volume
240.73K
Average Volume (3m)
486.62K
1-Year Change
-27.77%
Book Value / Share
23.14
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PRAX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
99.27
Upside
+159.33%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Praxis Precision Company Profile

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. The company offers cerebrum, a small molecule platform for CNS small molecule therapies and solidus, an antisense oligonucleotide platform to discover and develop antisense oligonucleotide. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase III clinical trial for the treatment of essential tremor; vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020; and PRAX-050. In addition, the company develops elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080; PRAX-090; and PRAX-100. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. The company was incorporated in 2015 and is based in Boston, Massachusetts.

Compare PRAX to Peers and Sector

Metrics to compare
PRAX
Peers
Sector
Relationship
P/E Ratio
−4.2x−0.5x−0.5x
PEG Ratio
−0.09−0.010.00
Price/Book
1.7x1.1x2.6x
Price / LTM Sales
90.2x10.2x3.0x
Upside (Analyst Target)
127.9%39.6%56.3%
Fair Value Upside
Unlock8.5%10.0%Unlock

Analyst Ratings

10 Buy
0 Hold
1 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 99.27
(+159.33% Upside)

Earnings

Latest Release
Feb 28, 2025
EPS / Forecast
-2.94 / -2.79
Revenue / Forecast
7.46M / 417.44K
EPS Revisions
Last 90 days

People Also Watch

2.40
PEPG
+6.67%
48.09
TARS
+3.49%
19.22
TILE
+2.34%
25.67
EWTX
+1.54%

FAQ

What Is the Praxis Precision (PRAX) Stock Price Today?

The Praxis Precision stock price today is 38.28

What Stock Exchange Does Praxis Precision Trade On?

Praxis Precision is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Praxis Precision?

The stock symbol for Praxis Precision is "PRAX."

What Is the Praxis Precision Market Cap?

As of today, Praxis Precision market cap is 771.85M.

What is Praxis Precision Earnings Per Share?

The Praxis Precision EPS is -10.21.

What Is the Next Praxis Precision Earnings Date?

Praxis Precision will release its next earnings report on 06 May 2025.

From a Technical Analysis Perspective, Is PRAX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.